Author: Alexander Lee
Alexander Lee
Alexander is the founder and author of Microcaps.ca, a leading resource for investors interested in the micro-cap stock market. With a passion for uncovering hidden gems in the world of small-cap stocks, Alexander combines in-depth research with years of experience in the financial markets to provide readers with valuable insights and timely analysis. Investors should conduct their own research or consult with a qualified investment advisor before making any investment decisions. The author of this article is not responsible for any gains or losses incurred from investing in companies mentioned.
Veta Resources Inc. is pleased to announce that MetaWorld Corporation (dba Syntheia) has received conditional approval to list the common shares of the company following the completion of the amalgamation transaction between the Company and Syntheia on the Canadian Securities Exchange (CSE). The Conditional Approval for listing on the CSE is subject to specific requirements set by the CSE, which include completion of the concurrent financing of Syntheia, posting the required documents on SEDAR, and completing all outstanding CSE application documentation and fees. Syntheia is actively working to meet these conditions promptly and anticipates final approval following the completion of…
Maritime Launch Services (Cboe CA:MAXQ) is currently advancing the development of Spaceport Nova Scotia’s launch support infrastructure. The Canadian commercial space company has chosen Voyager Space as the first owner authorized representative for engineering, design, and fabrication support. Voyager brings a wealth of aerospace and defense technology experience to the table and will collaborate with Maritime Launch to assess launch client requirements and integrate them into the existing site layout. The selection of Voyager Space as the first owner authorized representative underscores Maritime Launch Services’ commitment to meeting the design and development needs of their launch clients. This partnership aims…
In the last five years, Aurora Cannabis (TSX:ACB) has experienced significant underperformance compared to other marijuana stocks. Currently valued at $283 million by market cap, Aurora Cannabis shares have plummeted by 99% from their all-time highs, resulting in substantial losses for investors. Leading up to the legalization of recreational marijuana in Canada in 2018, investor optimism was high, causing steep valuations for Canadian cannabis producers like Aurora Cannabis. These companies, including Aurora Cannabis, invested heavily in expanding their manufacturing capabilities and acquiring smaller competitors at premium prices to gain market share. However, the heavily regulated cannabis market in Canada has…
Investing in dividend stocks of high quality can be a beneficial strategy to build long-term wealth and create a reliable source of passive income. It is important for investors to prioritize companies with strong financial performance, a healthy payout ratio, and a robust balance sheet, rather than simply chasing stocks with a high yield. One small-cap energy stock that has caught the attention of investors is Alvopetro Energy, valued at $172 million by market cap. As an independent Brazil-based upstream and midstream operator, Alvopetro Energy is the first integrated onshore natural gas provider in Brazil and has seen significant returns…
The information contained in this press release is not intended for distribution to United States newswire services or dissemination in the United States. Toronto, August 20, 2024 – O3 Mining Inc. (TSXV: OIII) (OTCQX: OIIIF) (“O3 Mining” or the “Corporation”) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (the “Underwriters”), wherein the Underwriters will purchase 13,660,000 units of the Corporation (the “Units”) at a price of $1.10 per Unit for total gross proceeds of $15,026,000 (the “Underwritten Offering”). Each Unit will consist of one common share…
On August 23, 2024, Flow Metals Corp. (CSE: FWM) successfully completed the first tranche of its non-brokered private placement, as previously disclosed on July 9, 2024. The company issued 3,300,000 non-flow-through common shares (NFT Shares) at a price of $0.05 per share, resulting in total gross proceeds of $165,000. Additionally, a finder’s fee of $1,200 was paid, and 24,000 non-transferable common share purchase warrants (Finder’s Warrants) were issued to a qualified party in connection with the placement. Each Finder’s Warrant entitles the holder to purchase one common share of the company at $0.065 per share within a 12-month period from…
In order to expedite the ongoing Stage 3 Resource Definition drilling program at the Fletcher Zone discovery within the Beta Hunt operation at the Company’s Southern Goldfields Operations, Westgold Resources Limited plans to deploy two additional drill rigs. The Company, based in Perth, Australia, is excited to share an overview of the Beta Hunt mine and provide updates on the progress of the drilling program at the Fletcher Zone. The recent drilling results have been promising, and the deployment of two extra drill rigs is expected to accelerate the program further. The Company aims to enhance the resource definition at…
Dakota Gold Corp. (NYSE American: DC) has reported promising results from exploration drilling at the Maitland Gold Project in South Dakota. The drilling has extended the area of continuous Tertiary epithermal gold mineralization at the Unionville Zone, with drill holes testing various gold mineralization sections in the central portion of the zone. Significant highlights include drill hole MA24C-053 intersecting 2.85 grams/tonne gold (g/t Au) over 13.7 meters and 1.44 g/t Au over 23.0 meters, and drill hole MA24C-048 intersecting multiple sections of gold mineralization including 4.34 g/t Au over 7.0 meters. Furthermore, the northernmost drill hole, MA24C-047, intersected deeper and…
Izotropic Corporation (CSE: IZO) has announced its regulatory strategy for the United States and European Union to introduce IzoView as a diagnostic device for patients with dense breast tissue. The regulatory pathway involves conducting a pre-market authorization clinical study with an estimated 400 patients at a cost of US$3.5 million. The company is currently finalizing a pre-submission and plans to submit to the U.S. Food and Drug Administration (FDA) within the next six to eight weeks. The strategy positions the IzoView Breast CT as a diagnostic imaging device to be used alongside digital breast tomosynthesis for patients with dense breast…
The following widget, identified as “kevel-widget-6”, is displayed on this webpage.